"Designing Growth Strategies is in our DNA"

Prescription Drugs Market Size, Share & Industry Analysis, By Product Type (Generics, Orphan, and Other Prescription Drugs), By Therapy (Oncology, Central Nervous System, Vaccines, Immunosuppressants, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, and Online Pharmacies), and Regional Forecast, 2026-2034

Last Updated: January 26, 2026 | Format: PDF | Report ID: FBI102709

 

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Prevalence of Key Diseases - By Key Countries/ Region, 2026
    2. Pipeline Analysis, By Key Players
    3. Key Industry Developments, By Key Players
    4. Regulatory Scenario, By Key Regions
    5. New Product Launches, By Key Players
    6. Impact of COVID-19 on the Market
  5. Global Prescription Drugs Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Product Type
      1. Generics
      2. Orphan
      3. Other Prescription Drugs
    2. Market Analysis, Insights and Forecast – By Application
      1. Oncology
      2. Central Nervous System
      3. Vaccines
      4. Immunosuppressants
      5. Others
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies & Drug Stores
      3. Online Pharmacies
    4. Market Analysis, Insights and Forecast – By Region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
  6. North America Prescription Drugs Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Product Type
      1. Generics
      2. Orphan
      3. Other Prescription Drugs
    2. Market Analysis, Insights and Forecast – By Application
      1. Oncology
      2. Central Nervous System
      3. Vaccines
      4. Immunosuppressants
      5. Others
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies & Drug Stores
      3. Online Pharmacies
    4. Market Analysis, Insights and Forecast – By Country
      1. U.S.
      2. Canada
  7. Europe Prescription Drugs Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Product Type
      1. Generics
      2. Orphan
      3. Other Prescription Drugs
    2. Market Analysis, Insights and Forecast – By Application
      1. Oncology
      2. Central Nervous System
      3. Vaccines
      4. Immunosuppressants
      5. Others
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies & Drug Stores
      3. Online Pharmacies
    4. Market Analysis, Insights and Forecast – By Country/ Sub-region
      1. U.K.
      2. Germany
      3. France
      4. Spain
      5. Italy
      6. Rest of Europe
  8. Asia Pacific Prescription Drugs Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Product Type
      1. Generics
      2. Orphan
      3. Other Prescription Drugs
    2. Market Analysis, Insights and Forecast – By Application
      1. Oncology
      2. Central Nervous System
      3. Vaccines
      4. Immunosuppressants
      5. Others
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies & Drug Stores
      3. Online Pharmacies
    4. Market Analysis, Insights and Forecast – By Country/ Sub-region
      1. Japan
      2. China
      3. India
      4. Australia
      5. Southeast Asia
      6. Rest of Asia Pacific
  9. Latin America Prescription Drugs Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Product Type
      1. Generics
      2. Orphan
      3. Other Prescription Drugs
    2. Market Analysis, Insights and Forecast – By Application
      1. Oncology
      2. Central Nervous System
      3. Vaccines
      4. Immunosuppressants
      5. Others
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies & Drug Stores
      3. Online Pharmacies
    4. Market Analysis, Insights and Forecast – By Country/ Sub-region
      1. Brazil
      2. Mexico
      3. Rest of Latin America
  10. Middle East & Africa Prescription Drugs Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Product Type
      1. Generics
      2. Orphan
      3. Other Prescription Drugs
    2. Market Analysis, Insights and Forecast – By Application
      1. Oncology
      2. Central Nervous System
      3. Vaccines
      4. Immunosuppressants
      5. Others
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies & Drug Stores
      3. Online Pharmacies
    4. Market Analysis, Insights and Forecast – By Country/ Sub-region
      1. GCC
      2. South Africa
      3. Rest of Middle East & Africa
  11. Competitive Analysis
    1. Global Market Share Analysis (2026)
    2. Company Profiles
      1. Novartis AG
        1. Overview
        2. Products & Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      2. Pfizer, Inc.
        1. Overview
        2. Products & Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      3. F. Hoffmann-La Roche Ltd.
        1. Overview
        2. Products & Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      4. Sanofi
        1. Overview
        2. Products & Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      5. Johnson & Johnson Services, Inc.
        1. Overview
        2. Products & Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      6. Merck & Co., Inc.
        1. Overview
        2. Products & Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      7. AbbVie, Inc.
        1. Overview
        2. Products & Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      8. GlaxoSmithKline plc.
        1. Overview
        2. Products & Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      9. AstraZeneca
        1. Overview
        2. Products & Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      10. CELGENE CORPORATION (BRISTOL-MYERS SQUIBB COMPANY)
        1. Overview
        2. Products & Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Prevalence of Key Diseases - By Key Countries/ Region, 2026
    2. Pipeline Analysis, By Key Players
    3. Key Industry Developments, By Key Players
    4. Regulatory Scenario, By Key Regions
    5. New Product Launches, By Key Players
    6. Impact of COVID-19 on the Market
  5. Global Prescription Drugs Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Product Type
      1. Generics
      2. Orphan
      3. Other Prescription Drugs
    2. Market Analysis, Insights and Forecast – By Application
      1. Oncology
      2. Central Nervous System
      3. Vaccines
      4. Immunosuppressants
      5. Others
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies & Drug Stores
      3. Online Pharmacies
    4. Market Analysis, Insights and Forecast – By Region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
  6. North America Prescription Drugs Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Product Type
      1. Generics
      2. Orphan
      3. Other Prescription Drugs
    2. Market Analysis, Insights and Forecast – By Application
      1. Oncology
      2. Central Nervous System
      3. Vaccines
      4. Immunosuppressants
      5. Others
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies & Drug Stores
      3. Online Pharmacies
    4. Market Analysis, Insights and Forecast – By Country
      1. U.S.
      2. Canada
  7. Europe Prescription Drugs Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Product Type
      1. Generics
      2. Orphan
      3. Other Prescription Drugs
    2. Market Analysis, Insights and Forecast – By Application
      1. Oncology
      2. Central Nervous System
      3. Vaccines
      4. Immunosuppressants
      5. Others
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies & Drug Stores
      3. Online Pharmacies
    4. Market Analysis, Insights and Forecast – By Country/ Sub-region
      1. U.K.
      2. Germany
      3. France
      4. Spain
      5. Italy
      6. Rest of Europe
  8. Asia Pacific Prescription Drugs Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Product Type
      1. Generics
      2. Orphan
      3. Other Prescription Drugs
    2. Market Analysis, Insights and Forecast – By Application
      1. Oncology
      2. Central Nervous System
      3. Vaccines
      4. Immunosuppressants
      5. Others
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies & Drug Stores
      3. Online Pharmacies
    4. Market Analysis, Insights and Forecast – By Country/ Sub-region
      1. Japan
      2. China
      3. India
      4. Australia
      5. Southeast Asia
      6. Rest of Asia Pacific
  9. Latin America Prescription Drugs Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Product Type
      1. Generics
      2. Orphan
      3. Other Prescription Drugs
    2. Market Analysis, Insights and Forecast – By Application
      1. Oncology
      2. Central Nervous System
      3. Vaccines
      4. Immunosuppressants
      5. Others
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies & Drug Stores
      3. Online Pharmacies
    4. Market Analysis, Insights and Forecast – By Country/ Sub-region
      1. Brazil
      2. Mexico
      3. Rest of Latin America
  10. Middle East & Africa Prescription Drugs Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Product Type
      1. Generics
      2. Orphan
      3. Other Prescription Drugs
    2. Market Analysis, Insights and Forecast – By Application
      1. Oncology
      2. Central Nervous System
      3. Vaccines
      4. Immunosuppressants
      5. Others
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies & Drug Stores
      3. Online Pharmacies
    4. Market Analysis, Insights and Forecast – By Country/ Sub-region
      1. GCC
      2. South Africa
      3. Rest of Middle East & Africa
  11. Competitive Analysis
    1. Global Market Share Analysis (2026)
    2. Company Profiles
      1. Novartis AG
        1. Overview
        2. Products & Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      2. Pfizer, Inc.
        1. Overview
        2. Products & Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      3. F. Hoffmann-La Roche Ltd.
        1. Overview
        2. Products & Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      4. Sanofi
        1. Overview
        2. Products & Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      5. Johnson & Johnson Services, Inc.
        1. Overview
        2. Products & Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      6. Merck & Co., Inc.
        1. Overview
        2. Products & Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      7. AbbVie, Inc.
        1. Overview
        2. Products & Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      8. GlaxoSmithKline plc.
        1. Overview
        2. Products & Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      9. AstraZeneca
        1. Overview
        2. Products & Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      10. CELGENE CORPORATION (BRISTOL-MYERS SQUIBB COMPANY)
        1. Overview
        2. Products & Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
Read Less

Figure 1: Global Prescription Drugs Market Revenue Breakdown (USD billion, %) by Region, 2026 & 2034

Figure 2: Global Prescription Drugs Market Value Share (%), by Product Type, 2026 & 2034

Figure 3: Global Prescription Drugs Market Value Share (%), By Application, 2026 & 2034

Figure 4: Global Prescription Drugs Market Value Share (%), by Distribution Channel, 2026 & 2034

Figure 5: Global Prescription Drugs Market Value (USD billion), by Region, 2026 & 2034

Figure 6: North America Prescription Drugs Market Value (USD billion), by Product Type, 2026 & 2034

Figure 7: North America Prescription Drugs Market Value Share (%), by Product Type, 2026

Figure 8: North America Prescription Drugs Market Value (USD billion), By Application, 2026 & 2034

Figure 9: North America Prescription Drugs Market Value Share (%), By Application, 2026

Figure 10: North America Prescription Drugs Market Value (USD billion), by Distribution Channel, 2026 & 2034

Figure 11: North America Prescription Drugs Market Value Share (%), by Distribution Channel, 2026

Figure 12: North America Prescription Drugs Market Value (USD billion), By Country, 2026 & 2034

Figure 13: North America Prescription Drugs Market Value Share (%), By Country, 2026

Figure 14: Europe Prescription Drugs Market Value (USD billion), by Product Type, 2026 & 2034

Figure 15: Europe Prescription Drugs Market Value Share (%), by Product Type, 2026

Figure 16: Europe Prescription Drugs Market Value (USD billion), By Application, 2026 & 2034

Figure 17: Europe Prescription Drugs Market Value Share (%), By Application, 2026

Figure 18: Europe Prescription Drugs Market Value (USD billion), by Distribution Channel, 2026 & 2034

Figure 19: Europe Prescription Drugs Market Value Share (%), by Distribution Channel, 2026

Figure 20: Europe Prescription Drugs Market Value (USD billion), By Country/ Sub-region, 2026 & 2034

Figure 21: Europe Prescription Drugs Market Value Share (%), By Country/ Sub-region, 2026

Figure 22: Asia Pacific Prescription Drugs Market Value (USD billion), by Product Type, 2026 & 2034

Figure 23: Asia Pacific Prescription Drugs Market Value Share (%), by Product Type, 2026

Figure 24: Asia Pacific Prescription Drugs Market Value (USD billion), By Application, 2026 & 2034

Figure 25: Asia Pacific Prescription Drugs Market Value Share (%), By Application, 2026

Figure 26: Asia Pacific Prescription Drugs Market Value (USD billion), by Distribution Channel, 2026 & 2034

Figure 27: Asia Pacific Prescription Drugs Market Value Share (%), by Distribution Channel, 2026

Figure 28: Asia Pacific Prescription Drugs Market Value (USD billion), By Country/ Sub-region, 2026 & 2034

Figure 29: Asia Pacific Prescription Drugs Market Value Share (%), By Country/ Sub-region, 2026

Figure 30: Latin America Prescription Drugs Market Value (USD billion), by Product Type, 2026 & 2034

Figure 31: Latin America Prescription Drugs Market Value Share (%), by Product Type, 2026

Figure 32: Latin America Prescription Drugs Market Value (USD billion), By Application, 2026 & 2034

Figure 33: Latin America Prescription Drugs Market Value Share (%), By Application, 2026

Figure 34: Latin America Prescription Drugs Market Value (USD billion), by Distribution Channel, 2026 & 2034

Figure 35: Latin America Prescription Drugs Market Value Share (%), by Distribution Channel, 2026

Figure 36: Latin America Prescription Drugs Market Value (USD billion), By Country/ Sub-region, 2026 & 2034

Figure 37: Latin America Prescription Drugs Market Value Share (%), By Country/ Sub-region, 2026

Figure 38: Middle East & Africa Prescription Drugs Market Value (USD billion), by Product Type, 2026 & 2034

Figure 39: Middle East & Africa Prescription Drugs Market Value Share (%), by Product Type, 2026

Figure 40: Middle East & Africa Prescription Drugs Market Value (USD billion), By Application, 2026 & 2034

Figure 41: Middle East & Africa Prescription Drugs Market Value Share (%), By Application, 2026

Figure 42: Middle East & Africa Prescription Drugs Market Value (USD billion), by Distribution Channel, 2026 & 2034

Figure 43: Middle East & Africa Prescription Drugs Market Value Share (%), by Distribution Channel, 2026

Figure 44: Middle East & Africa Prescription Drugs Market Value (USD billion), By Country/ Sub-region, 2026 & 2034

Figure 45: Middle East & Africa Prescription Drugs Market Value Share (%), By Country/ Sub-region, 2026

Figure 46: Global Prescription Drugs Market Share (%), By Company, 2026

Table 1: Global Prescription Drugs Market Revenue (USD billion) Forecast, by Product Type, 2021-2034

Table 2: Global Prescription Drugs Market Revenue (USD billion) Forecast, By Application, 2021-2034

Table 3: Global Prescription Drugs Market Revenue (USD billion) Forecast, by Distribution Channel, 2021-2034

Table 4: Global Prescription Drugs Market Revenue (USD billion) Forecast, by Region, 2021-2034

Table 5: North America Prescription Drugs Market Revenue (USD billion) Forecast, by Product Type, 2021-2034

Table 6: North America Prescription Drugs Market Revenue (USD billion) Forecast, By Application, 2021-2034

Table 7: North America Prescription Drugs Market Revenue (USD billion) Forecast, by Distribution Channel, 2021-2034

Table 8: North America Prescription Drugs Market Revenue (USD billion) Forecast, By Country, 2021-2034

Table 9: Europe Prescription Drugs Market Revenue (USD billion) Forecast, by Product Type, 2021-2034

Table 10: Europe Prescription Drugs Market Revenue (USD billion) Forecast, By Application, 2021-2034

Table 11: Europe Prescription Drugs Market Revenue (USD billion) Forecast, by Distribution Channel, 2021-2034

Table 12: Europe Prescription Drugs Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034

Table 13: Asia Pacific Prescription Drugs Market Revenue (USD billion) Forecast, by Product Type, 2021-2034

Table 14: Asia Pacific Prescription Drugs Market Revenue (USD billion) Forecast, By Application, 2021-2034

Table 15: Asia Pacific Prescription Drugs Market Revenue (USD billion) Forecast, by Distribution Channel, 2021-2034

Table 16: Asia Pacific Prescription Drugs Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034

Table 17: Latin America Prescription Drugs Market Revenue (USD billion) Forecast, by Product Type, 2021-2034

Table 18: Latin America Prescription Drugs Market Revenue (USD billion) Forecast, By Application, 2021-2034

Table 19: Latin America Prescription Drugs Market Revenue (USD billion) Forecast, by Distribution Channel, 2021-2034

Table 20: Latin America Prescription Drugs Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034

Table 21: Middle East & Africa Prescription Drugs Market Revenue (USD billion) Forecast, by Product Type, 2021-2034

Table 22: Middle East & Africa Prescription Drugs Market Revenue (USD billion) Forecast, By Application, 2021-2034

Table 23: Middle East & Africa Prescription Drugs Market Revenue (USD billion) Forecast, by Distribution Channel, 2021-2034

Table 24: Middle East & Africa Prescription Drugs Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034

  • 2021-2034
  • 2025
  • 2021-2024
  • 140
Download Free Sample

    man icon
    Mail icon
Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann